Related Experiment Video
Updated: Sep 26, 2026

Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
Long-Term Outcomes of Low-Dose Steroid Induction for Autoimmune Pancreatitis: A Multicenter Retrospective Study
Yuhei Iwasa1, Akinori Maruta2, Keisuke Iwata1
1Department of Gastroenterology, Gifu Municipal Hospital, Gifu, Japan.
Background:
Steroids are the first-line treatment for autoimmune pancreatitis (AIP); however, the impact of lower initial doses on relapse remains unclear.
Methods:
Ninety patients were divided into high-dose (HD; > 0.4 mg/kg/day) and low-dose (LD; ≤ 0.4 mg/kg/day) induction groups. The treatment response, relapse rate, and predictors of relapse were evaluated.
Results:
Sixty-two and 28 patients received HD and LD steroid induction. The treatment response (100% vs. 100%, p > 0.99), relapse rates (33.9% vs. 32.1%, p > 0.99) and relapse-free survival (hazard ratio [HR]: 0.86; log-rank test, p = 0.99) did not differ significantly between the groups. Multivariable analysis identified discontinuation of maintenance treatment within 3 years (HR: 5.32, p = 0.0004), larger pancreatic volume (HR: 1.02, p = 0.01), and a smaller IgG4 reduction rate at 1 month after initiation of steroid treatment (HR: 0.99, p = 0.02) as independent predictors of relapse. In contrast, LD steroid induction was not identified as a risk factor for relapse (HR: 0.99, p = 0.99).
Conclusions:
There were no significant differences between LD and HD steroid induction in terms of treatment efficacy or long-term outcomes in patients with AIP.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
